Y-mAbs Therapeutics, Inc at JPMorgan Healthcare Conference Transcript
Okay. We'll go ahead and get started. So welcome, everybody, to the Wednesday afternoon session of the 2020 JPMorgan Health Care Conference. My name's Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by Tessa Romero and Matt Bannon from the team.
Our next presenting company is Y-mAbs Therapeutics, and presenting on behalf of the company, we have CEO, Claus Møller. Claus?
¸ -
Thank you very much, Anupam, and thank you, everybody, for coming and listening to Y-mAbs' presentation. Let's jump right into it.
Our mission is to become the world leader in developing better and safer antibody-based pediatric oncology products addressing key unmet medical needs. We have a lot of passion behind this company. Our Chairman, Thomas Gad, had the unfortunate experience to have a daughter that went through the treatment with both our lead compound. Fortunately, she
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |